News

We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.

Sapphiros Is Pleased To Announce OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests In Sapphiros

READ MORE

Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement

READ MORE

Satio Receives Funding From ARPA-H to Develop SatioRx™ a Novel At-home, Remotely Controllable Transdermal Drug Delivery Device

READ MORE

Satio Partners with BARDA DRIVe to Develop a Novel Patch-based Ebolavirus Diagnostic

READ MORE

Sapphiros Appoints Industry Veteran Andrew Garfield to Lead Technology Transfer to Manufacturing

READ MORE

GrapheneDx, General Graphene Corp and Sapphiros Enter Into Strategic Partnership to Industrialize Graphene-Based Biosensors to Revolutionize Point of Care and Consumer Diagnostics

READ MORE